Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Clinical trial NCT00624325 · COMPLETED

Trial details

NCT number: NCT00624325
Sponsor: Foundation for Liver Research
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-07-01
Primary completion: 2010-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.